Transgenic Group (TSE:2342) Cash Flow for Dividends: 円-0 Mil (TTM As of Mar. 2026)


TSE:2342 Transgenic Group Inc TSE:2342
58 GF Score
Price 円212.00
GF Value 円257.39
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Cash Flow for Dividends?

Transgenic Group TSE:2342 +1.44% 58 Cash Flow for Dividends is 円-0 Mil as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 58/100 and a GF Value™ of 円257.39 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Transgenic Group's cash flow for dividends for the six months ended in Mar. 2026 was 円-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was 円-0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Transgenic Group's quarterly payment of dividends increased from Mar. 2025 (円0 Mil) to Sep. 2025 (円-0 Mil) but then declined from Sep. 2025 (円-0 Mil) to Mar. 2026 (円-0 Mil).

Transgenic Group's annual payment of dividends declined from Mar. 2024 (円-84 Mil) to Mar. 2025 (円-50 Mil) and declined from Mar. 2025 (円-50 Mil) to Mar. 2026 (円-0 Mil).

Transgenic Group Cash Flow for Dividends Related Terms

Transgenic Group Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Cash Flow for Dividends Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.10 -100.91 -83.82 -49.56 -0.18

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.89 -49.65 0.09 -0.13 -0.04
TSE:2342
58GF Score
Transgenic Group Inc TSE:2342
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of 円-0 Mil mean?
Transgenic Group (TSE:2342) has a Cash Flow for Dividends of 円-0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Transgenic Group and its competitors.
Is Transgenic Group's Cash Flow for Dividends too high?
Transgenic Group's current Cash Flow for Dividends is 円-0 Mil. Overall, Transgenic Group has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Cash Flow for Dividends compare to VRTX and REGN?
Transgenic Group's Cash Flow for Dividends of 円-0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Transgenic Group and its competitors. Transgenic Group's current Cash Flow for Dividends is 円-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.39, compared to a current price of 円212.00 — trading 17.6% below its estimated fair value. The current Cash Flow for Dividends is 円-0 Mil. Transgenic Group's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Cash Flow for Dividends is 円-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円212.00 is trading 17.6% below its estimated GF Value™ of 円257.39. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Cash Flow for Dividends: 円-0 Mil
  • GF Value™: 円257.39 vs. price of 円212.00 (17.6% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
58GF Score

Get the complete analysis for TSE:2342

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円212.00
Price
円257.39
GF Value